Loading
Latest filing published 23 Sept 2026 for Botanix Pharmaceuticals Ltd, €0. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Vincent Ippolito is a declared insider of Botanix Pharmaceuticals Ltd (senior executive), with filings sourced from ASX. Between 20 April 2026 and 22 September 2026, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 23 September 2026, reports a transaction of €0 in Botanix Pharmaceuticals Ltd. The latest purchase dates back some time: it was published 177 days ago, on 24 April 2026. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations